| [Eubacterium] siraeum| ATCC 29066| DSM 15702| DSM 3996| Eubacterium siraeum| Eubacterium siraeum Moore et al. 1976
Gut microbiota composition: Eubacterium species, including Eubacterium siraeum, are part of the human gut microbiota, which plays a crucial role in maintaining gut health and overall well-being. The gut microbiota is involved in various physiological processes, including digestion, metabolism, immune function, and protection against pathogens.
Short-chain fatty acid production: Many Eubacterium species are known to ferment dietary fibers and complex carbohydrates in the colon, producing short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. SCFAs are important energy sources for colonocytes (cells lining the colon) and have been associated with various health benefits, including maintaining gut barrier function, regulating immune responses, and influencing metabolic processes.
Immune modulation: Certain Eubacterium species have been implicated in immunomodulation and regulation of immune responses in the gut. They may interact with the host immune system and contribute to immune tolerance, inflammation control, and defense against pathogens. Dysregulation of immune-microbiota interactions has been linked to various inflammatory and autoimmune conditions.
Metabolic health: The gut microbiota, including Eubacterium species, plays a role in metabolic health and may influence host metabolism, energy balance, and risk of metabolic diseases such as obesity, type 2 diabetes, and cardiovascular disease. Some Eubacterium species have been associated with beneficial metabolic effects, although their specific contributions are not fully understood.
Disease associations: While Eubacterium siraeum has not been extensively studied in the context of human health and disease, alterations in the abundance or composition of Eubacterium species have been reported in various health conditions, including inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), colorectal cancer, and metabolic disorders. However, whether these alterations are causally related to disease pathogenesis or are secondary to underlying disease processes remains to be elucidated.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 2.74 | 0 | 0 | 1 | 141410 | 0 | 47516 | 8547.6 | 1348 | 19881.6 | 0 | 17737 | 0 %ile | 100 %ile |
thorne | 100 | 163 | 90332 | 0 | 48215 | 9416.8 | 879 | 19795.2 | 317 | 16621 | 0 %ile | 100 %ile | ||
thryve | 92.6 | 0 | 6143 | 54 | 7691 | 0 | 37427 | 5888.7 | 500 | 16090.8 | 0 | 8375 | 11.4 %ile | 90.6 %ile |
ubiome | 0.13 | 0 | 2455 | 2455 | 2455 | 2455 | 2455 | 0 %ile | 99 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 443.82 | 11962 | 0.0444 | 1.1962 |
XenoGene | 1500 | 37000 | 0.15 | 3.7 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSightRdp | 28.125 % | 0.588 % | 0.492 % | 9.0 | 32 |
CosmosId | 62.5 % | 1.376 % | 3.327 % | 20.0 | 32 |
custom | 18.644 % | 0.598 % | 0.978 % | 11.0 | 59 |
es-xenogene | 41.379 % | 0.441 % | 0.391 % | 12.0 | 29 |
Microba | 17.857 % | 0.908 % | 0.838 % | 5.0 | 28 |
Microba1 | 100 % | 2.39 % | % | 1.0 | 1 |
SequentiaBiotech | 30.556 % | 0.698 % | 0.905 % | 11.0 | 36 |
Thorne | 87.5 % | 0.492 % | 1.295 % | 77.0 | 88 |
Thryve | 92.842 % | 0.603 % | 1.697 % | 1284.0 | 1383 |
uBiome | 0.126 % | 0.245 % | % | 1.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.